MPS Pharmaa Limited (BOM:531686)

Market Cap	32.11M
Revenue (ttm)	437.20K
Net Income (ttm)	-8.94M
Shares Out	19.11M
EPS (ttm)	-0.47
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,917
Average Volume	2,179
Open	1.760
Previous Close	1.760
Day's Range	1.680 - 1.760
52-Week Range	1.680 - 4.290
Beta	-0.08
RSI	23.98
Earnings Date	Feb 2, 2026

About MPS Pharmaa

MPS Pharmaa Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers generic products, including antibacterials, antiallergics, antifungals, anthelminthics, antihypertensives, antimalarials, antituberculosis, corticosteroids, erectile dysfunction, gastrointestinal agents, sedatives, and others, as well as analgesic, antipyretic, and anti-inflammatory products. It also offers ethical products, such as Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin, and Chewfe-...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 18
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531686

Financial Performance

In 2024, MPS Pharmaa's revenue was 477,204, a decrease of -49.05% compared to the previous year's 936,669. Losses were -8.98 million, 8.05% more than in 2023.